GE HealthCare to Integrate AI-Enabled Solutions to its Radiation Oncology Portfolio

The company plans to launch an updated iRT solution and add spectronic medical’s software to optimize the radiation oncology portfolio

GE HealthCare, a leading global healthcare solutions provider, has announced the expansion of its radiation oncology portfolio.

The global player also announced the US FDA 510(k) clearance of MR Contour DL, an AI model that uses deep learning for organs at risk (OAR) segmentation.

MR Contour DL leverages the soft-tissue detail of MR images to create precise organ contours of OAR during radiation therapy treatment planning, a process that was previously entirely manual, bringing efficiency, consistency, and accuracy.

The model is capable of segmenting 37 organs and structures in the head-neck and pelvic regions based on standard 2D or 3D MR image datasets.

MR Contour DL will be integrated into GE HealthCare’s iRT digital solution for radiation therapy workflow management, reducing diagnostic time and workload.

Dr Carl Siversson, CEO, Spectronic Medical said "Spectronic Medical was founded on the vision that advanced MRI and AI technologies can unlock entirely new possibilities in radiotherapy.”

Moreover, GE HealthCare plans to showcase its newly updated iRT solution. Building on the successful first generation iRT, the latest version provides significant enhancements to unlock third party AI-driven workflows.

The updated solution incorporates multiple applications to run simultaneously for more complex workflows.

Additionally, the integration of MR imaging workflows, will shorten the timeline to treatment over conventional CT for certain body parts including head-neck, brain and pelvic use-cases.

Stay tuned for more such updates on Digital Health News.